Stock CONTEXT THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Context Therapeutics Inc. Nasdaq

Equities

US21077P1084

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-07-16 EDT 		5-day change 1st Jan Change
2.19 USD -0.45% Intraday chart for Context Therapeutics Inc. +12.89% +93.81%
05-08 Context Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-06 Context Therapeutics Inc. announced that it has received $99.992767 million in funding from Ally Bridge Group, Avidity Partners, LLC, Blue Owl Healthcare Opportunities, Deep Track Capital, LP, Driehaus Capital Management LLC, Great Point Partners, LLC CI

Income Statement Evolution (Annual data)

Fiscal Period:
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period:
Estimates

Balance Sheet Analysis

Fiscal Period:
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
Number of Analysts
0
Last Close Price
-
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+25.83% 46.56B
LONZA GROUP AG Stock Lonza Group AG
+45.38% 41.67B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.69% 41.16B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+30.52% 32.4B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+22.30% 28.18B
CELLTRION, INC. Stock Celltrion, Inc.
-6.35% 28.1B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+49.25% 14.52B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+49.18% 13.74B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+3.45% 12.17B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. Financials Context Therapeutics Inc.